2013-2028 Report on Global Cancer Anorexia-Cachexia Syndrome Drug Market by Player, Region, Type, Application and Sales Channel
SKU ID :MAR-13251228 | Published Date: 01-Mar-2019 | No. of pages: 105Description
TOC
Table of Contents
Chapter 1 Cancer Anorexia-Cachexia Syndrome Drug Market Overview
1.1 Cancer Anorexia-Cachexia Syndrome Drug Definition
1.2 Global Cancer Anorexia-Cachexia Syndrome Drug Market Size Status and Outlook (2013-2028)
1.3 Global Cancer Anorexia-Cachexia Syndrome Drug Market Size Comparison by Region (2013-2028)
1.4 Global Cancer Anorexia-Cachexia Syndrome Drug Market Size Comparison by Type (2013-2028)
1.5 Global Cancer Anorexia-Cachexia Syndrome Drug Market Size Comparison by Application (2013-2028)
1.6 Global Cancer Anorexia-Cachexia Syndrome Drug Market Size Comparison by Sales Channel (2013-2028)
1.7 Cancer Anorexia-Cachexia Syndrome Drug Market Dynamics
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/ Expansion)
Chapter 2 Cancer Anorexia-Cachexia Syndrome Drug Market Segment Analysis by Player
2.1 Global Cancer Anorexia-Cachexia Syndrome Drug Sales and Market Share by Player (2016-2018)
2.2 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue and Market Share by Player (2016-2018)
2.3 Global Cancer Anorexia-Cachexia Syndrome Drug Average Price by Player (2016-2018)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Cancer Anorexia-Cachexia Syndrome Drug Market Segment Analysis by Type
3.1 Global Cancer Anorexia-Cachexia Syndrome Drug Market by Type
3.1.1 NEO-1940
3.1.2 C-1889
3.1.3 DLN-101
3.1.4 Foxo1-nRNA
3.1.5 AVGN-7
3.2 Global Cancer Anorexia-Cachexia Syndrome Drug Sales and Market Share by Type (2013-2018)
3.3 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue and Market Share by Type (2013-2018)
3.4 Global Cancer Anorexia-Cachexia Syndrome Drug Average Price by Type (2013-2018)
3.5 Leading Players of Cancer Anorexia-Cachexia Syndrome Drug by Type in 2017
3.6 Conclusion of Segment by Type
Chapter 4 Cancer Anorexia-Cachexia Syndrome Drug Market Segment Analysis by Application
4.1 Global Cancer Anorexia-Cachexia Syndrome Drug Market by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Cancer Anorexia-Cachexia Syndrome Drug Sales and Market Share by Application (2013-2018)
4.3 Leading Consumers of Cancer Anorexia-Cachexia Syndrome Drug by Application in 2017
4.4 Conclusion of Segment by Application
Chapter 5 Cancer Anorexia-Cachexia Syndrome Drug Market Segment Analysis by Sales Channel
5.1 Global Cancer Anorexia-Cachexia Syndrome Drug Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global Cancer Anorexia-Cachexia Syndrome Drug Sales and Market Share by Sales Channel (2013-2018)
5.3 Leading Distributors/Dealers of Cancer Anorexia-Cachexia Syndrome Drug by Sales Channel in 2017
5.4 Conclusion of Segment by Sales Channel
Chapter 6 Cancer Anorexia-Cachexia Syndrome Drug Market Segment Analysis by Region
6.1 Global Cancer Anorexia-Cachexia Syndrome Drug Market Size and CAGR by Region (2013-2028)
6.2 Global Cancer Anorexia-Cachexia Syndrome Drug Sales and Market Share by Region (2013-2018)
6.3 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue and Market Share by Region (2013-2018)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America Cancer Anorexia-Cachexia Syndrome Drug Market Share by Type
6.4.3 North America Cancer Anorexia-Cachexia Syndrome Drug Market Share by Application
6.4.4 United States
6.4.5 Canada
6.4.6 Mexico
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe Cancer Anorexia-Cachexia Syndrome Drug Market Share by Type
6.5.3 Europe Cancer Anorexia-Cachexia Syndrome Drug Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Russia
6.5.9 Spain
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Market Share by Type
6.6.3 Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America Cancer Anorexia-Cachexia Syndrome Drug Market Share by Type in 2017
6.7.3 South America Cancer Anorexia-Cachexia Syndrome Drug Market Share by Application in 2017
6.7.4 Brazil
6.7.5 Argentina
6.7.6 Colombia
6.7.7 Chile
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Market Share by Type
6.8.3 Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Market Share by Application
6.8.4 Egypt
6.8.5 Saudi Arabia
6.8.6 South Africa
6.8.7 Nigeria
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Cancer Anorexia-Cachexia Syndrome Drug Players
7.1 Acacia Pharma Ltd
7.1.1 Company Snapshot
7.1.2 Product/Business Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.1.4 Strategy and SWOT Analysis
7.2 Aeterna Zentaris Inc
7.3 Aphios Corp
7.4 Incyte Corp
7.5 Lakewood-Amedex Inc
7.6 Novartis AG
7.7 Obexia AG
7.8 PsiOxus Therapeutics Ltd
7.9 RaQualia Pharma Inc
7.10 Viking Therapeutics Inc
Chapter 8 Upstream and Downstream Analysis of Cancer Anorexia-Cachexia Syndrome Drug
8.1 Industrial Chain of Cancer Anorexia-Cachexia Syndrome Drug
8.2 Upstream of Cancer Anorexia-Cachexia Syndrome Drug
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.2.4 Manufacturing Cost Structure
8.2.5 Manufacturing Process
8.3 Downstream of Cancer Anorexia-Cachexia Syndrome Drug
8.3.1 Leading Distributors/Dealers of Cancer Anorexia-Cachexia Syndrome Drug
8.3.2 Leading Consumers of Cancer Anorexia-Cachexia Syndrome Drug
Chapter 9 Development Trend of Cancer Anorexia-Cachexia Syndrome Drug (2018-2028)
9.1 Global Cancer Anorexia-Cachexia Syndrome Drug Market Size (Sales and Revenue) Forecast (2018-2028)
9.2 Global Cancer Anorexia-Cachexia Syndrome Drug Market Size and CAGR Forecast by Region (2018-2028)
9.3 Global Cancer Anorexia-Cachexia Syndrome Drug Market Size and CAGR Forecast by Type (2018-2028)
9.4 Global Cancer Anorexia-Cachexia Syndrome Drug Market Size and CAGR Forecast by Application (2018-2028)
9.5 Global Cancer Anorexia-Cachexia Syndrome Drug Market Size Forecast by Sales Channel (2018-2028)
Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification
Tables & Figures
List of Tables and Figures
Figure Cancer Anorexia-Cachexia Syndrome Drug Example
Figure Global Cancer Anorexia-Cachexia Syndrome Drug Revenue (Million $) Status and Outlook (2013-2028)
Figure Global Cancer Anorexia-Cachexia Syndrome Drug Revenue (Million $) Comparison by Region (2013-2028)
Figure Global Cancer Anorexia-Cachexia Syndrome Drug Sales Comparison by Type (2013-2028)
Figure Global Cancer Anorexia-Cachexia Syndrome Drug Sales Comparison by Application (2013-2028)
Figure Global Cancer Anorexia-Cachexia Syndrome Drug Sales Comparison by Sales Channel (2013-2028)
Table Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Player (2016-2018)
Table Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Player (2016-2018)
Figure Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Player in 2017
Table Global Cancer Anorexia-Cachexia Syndrome Drug Revenue (Million $) by Player (2016-2018)
Table Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Player (2016-2018)
Figure Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Player in 2017
Table Global Cancer Anorexia-Cachexia Syndrome Drug Average Price by Player (2016-2018)
Figure Global Cancer Anorexia-Cachexia Syndrome Drug Average Price by Player in 2017
Figure Global Cancer Anorexia-Cachexia Syndrome Drug Players Competition Situation – Top 5 Players’ Revenue Market Share in 2017
Figure Global Cancer Anorexia-Cachexia Syndrome Drug Players Competition Trends – Top 5 Players’ Revenue Market Share in 2018
Figure Example of NEO-1940
Figure Global NEO-1940 Sales and Growth Rate (2013-2018)
Figure Example of C-1889
Figure Global C-1889 Sales and Growth Rate (2013-2018)
Figure Example of DLN-101
Figure Global DLN-101 Sales and Growth Rate (2013-2018)
Figure Example of Foxo1-nRNA
Figure Global Foxo1-nRNA Sales and Growth Rate (2013-2018)
Figure Example of AVGN-7
Figure Global AVGN-7 Sales and Growth Rate (2013-2018)
Table Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2013-2018)
Table Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Type (2013-2018)
Figure Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Type in 2017
Table Global Cancer Anorexia-Cachexia Syndrome Drug Revenue (Million $) by Type (2013-2018)
Table Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Type (2013-2018)
Figure Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Type in 2017
Table Global Cancer Anorexia-Cachexia Syndrome Drug Average Price by Type (2013-2018)
Figure Global Cancer Anorexia-Cachexia Syndrome Drug Average Price by Type in 2017
Table Leading Players of Cancer Anorexia-Cachexia Syndrome Drug by Type in 2017
Figure Example of Hospital
Figure Global Cancer Anorexia-Cachexia Syndrome Drug for Hospital Sales and Growth Rate (2013-2018)
Figure Example of Clinic
Figure Global Cancer Anorexia-Cachexia Syndrome Drug for Clinic Sales and Growth Rate (2013-2018)
Figure Example of Others
Figure Global Cancer Anorexia-Cachexia Syndrome Drug for Others Sales and Growth Rate (2013-2018)
Table Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2013-2018)
Table Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Application (2013-2018)
Figure Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Application in 2017
Table Leading Consumers of Cancer Anorexia-Cachexia Syndrome Drug by Application in 2017
Figure Example of Direct Channel
Figure Global Cancer Anorexia-Cachexia Syndrome Drug for Direct Channel Sales and Growth Rate (2013-2018)
Figure Example of Distribution Channel
Figure Global Cancer Anorexia-Cachexia Syndrome Drug for Distribution Channel Sales and Growth Rate (2013-2018)
Table Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Sales Channel (2013-2018)
Table Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Sales Channel (2013-2018)
Figure Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Sales Channel in 2017
Table Leading Distributors/Dealers of Cancer Anorexia-Cachexia Syndrome Drug by Sales Channel in 2017
Table Global Cancer Anorexia-Cachexia Syndrome Drug Market Size and CAGR by Region (2013-2028)
Table Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Region (2013-2018)
Table Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Region (2013-2018)
Figure Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Region in 2017
Table Global Cancer Anorexia-Cachexia Syndrome Drug Revenue (Million $) by Region (2013-2018)
Table Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Region (2013-2018)
Figure Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Region in 2017
Table North America Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2013-2018)
Figure North America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Country (2013-2018)
Table North America Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country (2013-2018)
Figure North America Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Country (2013-2018)
Figure North America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Type in 2017
Figure North America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Application in 2017
Figure United States Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2013-2018)
Figure United States Cancer Anorexia-Cachexia Syndrome Drug Revenue (Million $) and Growth Rate (2013-2018)
Figure Canada Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2013-2018)
Figure Canada Cancer Anorexia-Cachexia Syndrome Drug Revenue (Million $) and Growth Rate (2013-2018)
Figure Mexico Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2013-2018)
Figure Mexico Cancer Anorexia-Cachexia Syndrome Drug Revenue (Million $) and Growth Rate (2013-2018)
Table Europe Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2013-2018)
Figure Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Country (2013-2018)
Table Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country (2013-2018)
Figure Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Country (2013-2018)
Figure Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Type in 2017
Figure Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Application in 2017
Figure Germany Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2013-2018)
Figure Germany Cancer Anorexia-Cachexia Syndrome Drug Revenue (Million $) and Growth Rate (2013-2018)
Figure UK Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2013-2018)
Figure UK Cancer Anorexia-Cachexia Syndrome Drug Revenue (Million $) and Growth Rate (2013-2018)
Figure France Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2013-2018)
Figure France Cancer Anorexia-Cachexia Syndrome Drug Revenue (Million $) and Growth Rate (2013-2018)
Figure Italy Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2013-2018)
Figure Italy Cancer Anorexia-Cachexia Syndrome Drug Revenue (Million $) and Growth Rate (2013-2018)
Figure Russia Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2013-2018)
Figure Russia Cancer Anorexia-Cachexia Syndrome Drug Revenue (Million $) and Growth Rate (2013-2018)
Figure Spain Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2013-2018)
Figure Spain Cancer Anorexia-Cachexia Syndrome Drug Revenue (Million $) and Growth Rate (2013-2018)
Table Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2013-2018)
Figure Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Country (2013-2018)
Table Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country (2013-2018)
Figure Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Country (2013-2018)
Figure Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Type in 2017
Figure Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Application in 2017
Figure China Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2013-2018)
Figure China Cancer Anorexia-Cachexia Syndrome Drug Revenue (Million $) and Growth Rate (2013-2018)
Figure Japan Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2013-2018)
Figure Japan Cancer Anorexia-Cachexia Syndrome Drug Revenue (Million $) and Growth Rate (2013-2018)
Figure Korea Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2013-2018)
Figure Korea Cancer Anorexia-Cachexia Syndrome Drug Revenue (Million $) and Growth Rate (2013-2018)
Figure India Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2013-2018)
Figure India Cancer Anorexia-Cachexia Syndrome Drug Revenue (Million $) and Growth Rate (2013-2018)
Figure Southeast Asia Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2013-2018)
Figure Southeast Asia Cancer Anorexia-Cachexia Syndrome Drug Revenue (Million $) and Growth Rate (2013-2018)
Figure Australia Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2013-2018)
Figure Australia Cancer Anorexia-Cachexia Syndrome Drug Revenue (Million $) and Growth Rate (2013-2018)
Table South America Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2013-2018)
Figure South America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Country (2013-2018)
Table South America Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country (2013-2018)
Figure South America Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Country (2013-2018)
Figure South America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Type in 2017
Figure South America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Application in 2017
Figure Brazil Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2013-2018)
Figure Brazil Cancer Anorexia-Cachexia Syndrome Drug Revenue (Million $) and Growth Rate (2013-2018)
Figure Argentina Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2013-2018)
Figure Argentina Cancer Anorexia-Cachexia Syndrome Drug Revenue (Million $) and Growth Rate (2013-2018)
Figure Colombia Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2013-2018)
Figure Colombia Cancer Anorexia-Cachexia Syndrome Drug Revenue (Million $) and Growth Rate (2013-2018)
Figure Chile Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2013-2018)
Figure Chile Cancer Anorexia-Cachexia Syndrome Drug Revenue (Million $) and Growth Rate (2013-2018)
Table Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2013-2018)
Figure Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Country (2013-2018)
Table Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country (2013-2018)
Figure Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Country (2013-2018)
Figure Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Type in 2017
Figure Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Application in 2017
Figure Egypt Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2013-2018)
Figure Egypt Cancer Anorexia-Cachexia Syndrome Drug Revenue (Million $) and Growth Rate (2013-2018)
Figure Saudi Arabia Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2013-2018)
Figure Saudi Arabia Cancer Anorexia-Cachexia Syndrome Drug Revenue (Million $) and Growth Rate (2013-2018)
Figure South Africa Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2013-2018)
Figure South Africa Cancer Anorexia-Cachexia Syndrome Drug Revenue (Million $) and Growth Rate (2013-2018)
Figure Nigeria Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate (2013-2018)
Figure Nigeria Cancer Anorexia-Cachexia Syndrome Drug Revenue (Million $) and Growth Rate (2013-2018)
Table Company Snapshot of Acacia Pharma Ltd
Table Cancer Anorexia-Cachexia Syndrome Drug Introduction of Acacia Pharma Ltd
Table Cancer Anorexia-Cachexia Syndrome Drug Sales, Price, Revenue, Gross Margin and Market Share of Acacia Pharma Ltd (2016-2018)
Table Industrial Chain of Cancer Anorexia-Cachexia Syndrome Drug
Table Manufacturing Cost Structure of Cancer Anorexia-Cachexia Syndrome Drug
Table General Manufacturing Process of Cancer Anorexia-Cachexia Syndrome Drug
Table Leading Distributors/Dealers of Cancer Anorexia-Cachexia Syndrome Drug
Table Leading Consumers of Cancer Anorexia-Cachexia Syndrome Drug
Figure Global Cancer Anorexia-Cachexia Syndrome Drug Sales and Growth Rate Forecast (2018-2028)
Figure Global Cancer Anorexia-Cachexia Syndrome Drug Revenue and Growth Rate Forecast (2018-2028)
Table Global Cancer Anorexia-Cachexia Syndrome Drug Market Size and CAGR Forecast by Region (2018-2028)
Table Global Cancer Anorexia-Cachexia Syndrome Drug Market Size and CAGR Forecast by Type (2018-2028)
Table Global Cancer Anorexia-Cachexia Syndrome Drug Market Size and CAGR Forecast by Application (2018-2028)
Table Global Cancer Anorexia-Cachexia Syndrome Drug Market Size and CAGR Forecast by Sales Channel (2018-2028)
Companies
Acacia Pharma Ltd
Aeterna Zentaris Inc
Aphios Corp
Incyte Corp
Lakewood-Amedex Inc
Novartis AG
Obexia AG
PsiOxus Therapeutics Ltd
RaQualia Pharma Inc
Viking Therapeutics Inc
- PRICE
-
$2500$5000